ACHN Market Cap History
Below is a table of the ACHN market cap history going back to 3/9/2010:

Date ACHN Market Cap
3/9/2010101.70M
5/7/201088.22M
10/25/2010161.63M
3/1/2011346.26M
8/1/2011515.92M
11/1/2011421.95M
3/1/2012753.66M
5/1/2012466.26M
8/1/2012476.55M
11/1/2012743.49M
2/11/2013728.03M
5/1/2013683.62M
8/1/2013679.40M
11/1/2013244.59M
3/3/2014348.45M
5/1/2014269.09M
8/1/2014688.43M
5/1/20151.07B
2/19/2016915.49M
8/1/20161.15B
11/1/2016847.42M
2/20/2017583.80M
5/1/2017482.64M
8/1/2017551.15M
10/27/2017537.85M
2/20/2018415.06M
5/1/2018522.92M
8/1/2018356.17M
11/1/2018428.32M
3/1/2019370.37M
5/1/2019403.69M
8/1/2019630.02M

Also see: ACHN Shares Outstanding History
and ACHN YTD Return
ACHN Historical Market Cap:
+21.41% CAGR
ACHN Historical Market Cap: +21.41% CAGR

Mouse over chart for data details
3/9/2010 ...8/1/2019
Achillion Pharmaceuticals is a biopharmaceutical company. Co. is engaged in the discovery and development of small molecule drug therapies for immune system disorders. Co. is advancing orally administered small molecules from its platform that target complement factor D, an essential protein of the alternative pathway. The alternative pathway plays a role in a number of disease conditions, including therapeutic areas of nephrology, hematology, ophthalmology and neurology. Initially Co. is targeting C3 glomerulopathy, and immune complex membranoproliferative glomerulonephritis, two related rare diseases affecting the kidney, and paroxysmal nocturnal hemoglobinuria, a blood disorder. We show 32 historical shares outstanding datapoints in our ACHN shares outstanding history coverage, used to compute ACHN market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ACHN market cap history over the course of time is important for investors interested in comparing ACHN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ACHN versus a peer is one thing; comparing ACHN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ACHN can fluctuate over the course of history. With this page we aim to empower investors researching ACHN by allowing them to research the ACHN market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ACHN:
ACHN SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Achillion Pharmaceuticals (ACHN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ACHV Market Cap History
ACOR Market Cap History
ACRS Market Cap History
ACRX Market Cap History
ACST Market Cap History
ADMA Market Cap History
ADMP Market Cap History
ADMS Market Cap History
ADPT Market Cap History
ADRO Market Cap History
More Healthcare companies »

 

ACHN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.